Molecular characterization of ctDNA from Chinese patients with advanced gastric adenocarcinoma reveals actionable alterations for targeted and immune therapy

Authors:

Abstract
Circulating tumor DNA (ctDNA) is considered an ideal sample type for genotyping patients with advanced unresectable cancer to inform treatment decision. It
Funding Information
  • The capital health research and development of special (2018-2-1023)
  • the Pilot Project (3rd Round) to Reform Public Development of Beijing Municipal Medical Research Institutes (2019-1)

This publication has 47 references indexed in Scilit: